OpenAI Group PBC announced this morning that it has acquired drug development software startup Orchestra Bio Inc. The acquisition is part of OpenAI’s strategy to expand its artificial intelligence (AI) solutions in the life sciences, specifically to shorten long and complex drug development chains. Orchestra Bio is developing…
